In this edition of the journal Corso et al. [1] assessed 5,226 breast cancer patients who underwent germline genetic testing for the BRCA1 and BRCA2 genes, of which 23 (0.4%) were diagnosed with metaplastic breast cancers. This evidence concerns the gene BRCA2 and breast carcinoma.